{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 451554162
| IUPAC_name = 1-phenyl-1-cyclohexyl-3-dimethylaminopropane
| image = Gamfexine.png
<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status = Unscheduled
| routes_of_administration = Oral
<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| ATC_prefix = none
| ATC_suffix =  
| PubChem = 31041
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3U2V80KPAL
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D04298
| CAS_number = 7273-99-6
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 28799
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C17H27N/c1-18(2)14-13-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3,5-6,9-10,16-17H,4,7-8,11-14H2,1-2H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = AJDSHXKJJDQZCJ-UHFFFAOYSA-N
<!--Chemical data-->
| C=17 | H=27 | N=1
| molecular_weight = 245.402 g/mol
| smiles = c1ccccc1C(CCN(C)C)C2CCCCC2
}}

'''Gamfexine''' ('''WIN-1,344''') is a centrally acting [[stimulant]] [[drug]], which was tested as an adjunct treatment for withdrawn patients with schizophrenia, but while effective for treating withdrawal it made psychotic symptoms worse.<ref>John H Biel. Annual Reports in Medicinal Chemistry, Volume 2. Academic Press 1966. p18.</ref>
==See also==
*[[Delucemine]]
== References ==
{{Reflist}}

{{Stimulants}}
{{Dopaminergics}}

[[Category:Stimulants]]
[[Category:Amines]]


{{nervous-system-drug-stub}}